Loading company…
Orbicular Pharmaceutical Technologies develops generic and specialty pharmaceutical products.
Orbicular's portfolio includes injectable formulations, drug-device combinations, ophthalmic suspensions, and nasal and inhalation products. Founded in 2010, the company is based in Hyderabad, India. In May 2024, it raised USD 20 million in venture funding from Tata Capital Private Equity to develop its product pipeline.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in